Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney de Novo Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Post-approval studies (Phase 4)Study completedNCT00240955
What this trial is testing

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Who this might be right for
Renal Transplantation
Novartis 79
Post-approval studies (Phase 4)Study completedNCT02432833
What this trial is testing

Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients

Who this might be right for
End Stage Renal Disease
Chiesi Farmaceutici S.p.A. 428
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Study completedNCT01802268
What this trial is testing

Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Helio Tedesco Silva Junior 320
Large-scale testing (Phase 3)Ended earlyNCT00311311
What this trial is testing

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Who this might be right for
AtherosclerosisKidney Failure
Pfizer 72
Testing effectiveness (Phase 2)Study completedNCT00257387
What this trial is testing

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 120
Early research (Phase 1)Ended earlyNCT01163799
What this trial is testing

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

Who this might be right for
Transplant; Failure, Kidney
Northwestern University 9
Post-approval studies (Phase 4)Study completedNCT00518375
What this trial is testing

Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

Who this might be right for
Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 250
Post-approval studies (Phase 4)Study completedNCT02500212
What this trial is testing

Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

Who this might be right for
Organ or Tissue Transplant; Complications
Chiesi Farmaceutici S.p.A. 75
Post-approval studies (Phase 4)Study completedNCT01950819
What this trial is testing

Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

Who this might be right for
End Stage Renal Disease (ESRD)Chronic Kidney Disease (CKD)Hemodialysis+2 more
Novartis Pharmaceuticals 2,037
Large-scale testing (Phase 3)Study completedNCT00004230
What this trial is testing

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Who this might be right for
Cancer
Northwestern University 35
Large-scale testing (Phase 3)Study completedNCT00239876
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 140
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Testing effectiveness (Phase 2)Study completedNCT00403416
What this trial is testing

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 215
Large-scale testing (Phase 3)Ended earlyNCT00284921
What this trial is testing

MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

Who this might be right for
De Novo Kidney Transplant
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT02137239
What this trial is testing

Regimen Optimization Study

Who this might be right for
Kidney Transplantation
Bristol-Myers Squibb 58
Large-scale testing (Phase 3)Study completedNCT00239811
What this trial is testing

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Large-scale testing (Phase 3)Study completedNCT00238992
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.

Who this might be right for
Kidney de Novo Transplant
Novartis Pharmaceuticals 144
Post-approval studies (Phase 4)Study completedNCT03968588
What this trial is testing

Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Ajou University School of Medicine 108
Next Page